These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 304199)

  • 21. Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
    Tefft M; Chabora BM; Rosen G
    Cancer; 1977 Feb; 39(2 Suppl):806-16. PubMed ID: 402197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
    Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
    Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. En bloc resections for osteogenic sarcoma.
    Marcove RC; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):165-8. PubMed ID: 6946289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
    Jaffe N; Frei E; Traggis D; Bishop Y
    N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
    Eilber FR; Grant T; Morton DL
    Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery.
    Rosen G; Huvos AG; Mosende C; Beattie EJ; Exelby PR; Capparos B; Marcove RC
    Cancer; 1978 Mar; 41(3):841-9. PubMed ID: 305817
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
    Schulz A; Fischer HP; Breithaupt H; Pralle H
    Onkologie; 1983 Dec; 6(6):296-304. PubMed ID: 6366675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy for primary osteogenic sarcoma.
    Cortes EP; Holland JF
    Surg Clin North Am; 1981 Dec; 61(6):1391-404. PubMed ID: 6976008
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination chemotherapy for osteosarcoma.
    Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
    Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
    Lee SY; Jeon DG; Kim SS; Jang JJ; Cho KJ
    J Korean Med Sci; 1993 Apr; 8(2):121-6. PubMed ID: 8397928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
    Rosen G; Marcove RC; Huvos AG; Caparros BI; Lane JM; Nirenberg A; Cacavio A; Groshen S
    J Cancer Res Clin Oncol; 1983; 106 Suppl():55-67. PubMed ID: 6604058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteosarcoma--the winds of change.
    Mills EE
    S Afr Med J; 1978 May; 53(18):695-8. PubMed ID: 308700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
    Rosen G; Nirenberg A
    Cancer Treat Rep; 1982 Sep; 66(9):1687-97. PubMed ID: 6981454
    [No Abstract]   [Full Text] [Related]  

  • 39. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy of osteogenic sarcoma: progress and perspectives.
    Frei E; Jaffe N; Gero M; Skipper H; Watts H
    J Natl Cancer Inst; 1978 Jan; 60(1):3-10. PubMed ID: 304894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.